全球生物模擬市場規模調查，按產品，按應用，按交付模式，按最終用途，按地區預測 2022-2028

到 2021 年，全球生物模擬市場價值約為 24 億美元，預計在 2022-2028 年的預測期內將以超過 16.2% 的健康增長率增長。

使用計算機軟件來模擬生物過程被稱為生物模擬。在藥物發現過程中使用稱為生物模擬的預測和分析工具來預測正在進行的實驗試驗的結果。疾病模擬使正在開發的新藥理學試劑的虛擬臨床試驗成為可能。生物模擬軟件在藥物發現和開發過程中有多種應用，因為它可以幫助製藥公司更快、更便宜地找到新藥。降低藥物發現和開發成本的日益增長的需求以及對生命科學行業的投資增加是推動全球市場需求的因素。例如，在 2021 年 4 月發表在國家生物技術信息中心的一項研究中，利用生物模擬工具 BIOiSIM 的計算機模擬是使用眾所周知的臨床前體外和體內數據集進行的。該試驗的目的是促進肺動脈高壓療法的再利用和對抗 COVID-19 藥物的開發。因此，越來越多地使用個性化醫療和不斷提高的技術進步將在未來幾年刺激市場增長。然而，缺乏技能和專業知識將阻礙 2022-2028 年預測期內的市場增長。

生物模擬全球市場研究考慮的主要地區是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於主要市場參與者的存在、醫療保健數字化的日益普及以及慢性病患病率的上升，北美已成為全球市場份額的主要地區。另一方面，預計亞太地區將在 2022-2028 年的預測期內呈現顯著的增長率。研發活動的增加以及公共和私人參與者不斷增加的舉措等因素將為整個亞太地區的生物模擬市場創造有利的增長前景。

本報告中包括的主要市場參與者是：

• Certara, USA
• Simulations Plus
• Dassault Systemes
• Schrodinger, Inc.
• Advanced Chemistry Development
• Chemical Computing Group ULC
• Physiomics Plc
• Rosa & Co. LLC
• Biosimulation Consulting Inc.
• Genedata AG

本研究的目的是確定近年來各個細分市場和國家/地區的市場規模，並預測未來八年的價值。本報告旨在捕捉所研究的每個地區和國家的行業的定性和定量方面。此外，它還提供了有關關鍵方面的詳細信息，例如定義市場未來增長的驅動因素和挑戰。此外，報告還應詳細分析主要參與者的競爭格局和產品供應，以及微觀市場中可供利益相關者投資的機會。市場的詳細細分和子細分如下所述。

按產品

軟件

服務

按應用程序

藥物開發

藥物發現

雜項

按交付模式

訂閱模式

所有權模式

按最終用戶

製藥和生物技術公司

CRO（合同研究組織

）

監管機構

學術研究機構

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考慮的年份是：

實際年份 - 2018 年、2019 年、2020 年

2021 年基準年

預測期 - 2022 年 至 2028 年

市場研究“全球生物模擬市場”的目標受眾

主要諮詢公司和顧問

大公司、中型公司、中小企業

風險投資

增值經銷商 (VAR)

第三方知識提供者

投資銀行家

投資者

內容

第 1 章執行摘要

• 市場快照
• 2020-2028 年全球市場和細分市場的估計和預測
  • 2020-2028 年按地區分列的生物模擬市場
  • 2020-2028 年按產品分類的生物模擬市場
  • 2020-2028 年按應用分列的生物模擬市場
  • 2020-2028 年生物模擬市場（按交付模式）
  • 生物模擬市場：按最終用途分類，2020-2028 年
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章生物模擬全球市場定義和範圍

• 調查目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第 3 章全球生物模擬市場動態

• 生物模擬市場影響分析（2020-2028）
  • 市場驅動力
    • 降低藥物發現和開發成本的需求日益增長
    • 增加對生命科學行業的投資
  • 市場挑戰
    • 缺乏技能或專業知識
  • 市場機會
    • 擴大個性化醫療的使用範圍
    • 不斷進步的技術進步

第四章全球生物模擬市場行業分析

• 波特的 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法（2018-2028）
• PEST 分析
  • 政治
  • 經濟
  • 社交
  • 技術
• 招商引資模式
• 分析師的結論和建議
• 熱門投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的整體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球生物模擬市場：按產品分類

• 市場快照
• 全球生物模擬市場：按產品、性能潛力分析
• 2018-2028 年世界生物模擬市場、按產品估計和預測
• 生物模擬市場，細分分析
  • 軟件
  • 服務

第 7 章：全球生物模擬市場：按應用分類

• 市場快照
• 世界生物模擬市場：按應用分列的性能和潛力分析
• 2018-2028 年全球生物模擬市場、估計和預測（按應用）
• 生物模擬市場，細分分析
  • 藥物開發
  • 藥物發現
  • 其他

第 8 章全球生物模擬市場：按交付模式

• 市場快照
• 世界生物模擬市場：交付模型的性能潛力分析
• 2018-2028 年世界生物模擬市場、按交付模型的估計和預測
• 生物模擬市場，細分分析
  • 訂閱模式
  • 所有權模式

第 9 章全球生物模擬市場，按最終用途分類

• 市場快照
• 全球生物模擬市場：最終用戶的表現 - 潛力分析
• 2018-2028 年世界生物模擬市場、最終用途估計和預測
• 生物模擬市場，細分分析
  • 製藥公司、生物技術公司
  • CRO（合同研究組織）
  • 監管機構
  • 學術研究所

第 10 章全球生物模擬市場：區域分析

• 全球生物模擬市場，區域市場快照
• 北美
  • 美國
    • 2018-2028 年按產品分類的估計和預測
    • 按應用劃分的估計和預測，2018-2028
    • 按交付模式劃分的估計和預測，2018-2028 年
    • 2018-2028 年最終用戶的估計和預測
  • 加拿大
• 歐洲生物模擬市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太生物模擬市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲生物模擬市場概況
  • 巴西
  • 墨西哥
• 世界其他地區

第 11 章衝突信息

• 頂級市場策略
• 公司簡介
  • Certara, USA
    • 主要信息
    • 概覽
    • 財務（取決於數據可用性）
    • 產品概覽
    • 近期發展狀況
  • Simulations Plus
  • Dassault Systemes
  • Schrodinger, Inc.
  • Advanced Chemistry Development
  • Chemical Computing Group ULC
  • Physiomics Plc
  • Rosa & Co. LLC
  • Biosimulation Consulting Inc.
  • Genedata AG

第 12 章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場估算
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global Biosimulation Market is valued at approximately USD 2.4 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.2% over the forecast period 2022-2028.

The use of computer software to simulate biological processes is known as biosimulation. A predictive and analytical tool called biosimulation is used in the drug discovery process to forecast the results of ongoing experimental trials. By running illness simulations, virtual clinical trials of novel pharmacological medications under development can be carried out. Biosimulation software has several uses in the pharmaceutical drug discovery and development process since it can help pharmaceutical companies find novel medications faster and more affordably. Increasing need to reduce drug discovery and development costs, as well as increasing investments in the life sciences industry, are factors that are accelerating the global market demand. For instance, in a study from April 2021 that was published in the National Center for Biotechnology Information, in silico modelling utilizing the biosimulation tool BIOiSIM was done using preclinical in vitro and in vivo datasets that were well-known. The goal of the trial was to expedite the repurposing of therapies for pulmonary hypertension and the development of COVID-19-fighting medications. Consequentially, increasing use of personalized medicine and rising technological advancements stimulate market growth in the approaching years. However, a lack of skills & expertise impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Biosimulation market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of key market players, increasing adoption of digitalization in healthcare, and rising prevalence of chronic diseases. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising research and development activities, and rising initiatives by public and private players would create lucrative growth prospects for the Biosimulation market across the Asia Pacific region.

Major market players included in this report are:

Certara, USA

Simulations Plus

Dassault Systemes

Schrodinger, Inc.

Advanced Chemistry Development

Chemical Computing Group ULC

Physiomics Plc

Rosa & Co. LLC

Biosimulation Consulting Inc.

Genedata AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Software

Services

By Application:

Drug Development

Drug Discovery

Others

By Delivery Model:

Subscription Models

Ownership Models

By End-Use:

Pharmaceutical & Biotechnology Companies

CROs

Regulatory Authorities

Academic Research Institutions

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Biosimulation Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Biosimulation Market, by Region, 2020-2028 (USD Billion)
  • 1.2.2. Biosimulation Market, by Product, 2020-2028 (USD Billion)
  • 1.2.3. Biosimulation Market, by Application, 2020-2028 (USD Billion)
  • 1.2.4. Biosimulation Market, by Delivery Model, 2020-2028 (USD Billion)
  • 1.2.5. Biosimulation Market, by End-Use, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biosimulation Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biosimulation Market Dynamics

• 3.1. Biosimulation Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing need to reduce drug discovery and development costs
    • 3.1.1.2. Increasing investments in the life sciences industry
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of skills and expertise
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing use of personalized medicine
    • 3.1.3.2. Rising Technological advancements

Chapter 4. Global Biosimulation Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biosimulation Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Biosimulation Market by Product, Performance - Potential Analysis
• 6.3. Global Biosimulation Market Estimates & Forecasts by Product, 2018-2028 (USD Billion)
• 6.4. Biosimulation Market, Sub Segment Analysis
  • 6.4.1. Software
  • 6.4.2. Services

Chapter 7. Global Biosimulation Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Biosimulation Market by Application, Performance - Potential Analysis
• 7.3. Global Biosimulation Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
• 7.4. Biosimulation Market, Sub Segment Analysis
  • 7.4.1. Drug Development
  • 7.4.2. Drug Discovery
  • 7.4.3. Others

Chapter 8. Global Biosimulation Market, by Delivery Model

• 8.1. Market Snapshot
• 8.2. Global Biosimulation Market by Delivery Model, Performance - Potential Analysis
• 8.3. Global Biosimulation Market Estimates & Forecasts by Delivery Model, 2018-2028 (USD Billion)
• 8.4. Biosimulation Market, Sub Segment Analysis
  • 8.4.1. Subscription Models
  • 8.4.2. Ownership Models

Chapter 9. Global Biosimulation Market, by End-Use

• 9.1. Market Snapshot
• 9.2. Global Biosimulation Market by End-Use, Performance - Potential Analysis
• 9.3. Global Biosimulation Market Estimates & Forecasts by End-Use, 2018-2028 (USD Billion)
• 9.4. Biosimulation Market, Sub Segment Analysis
  • 9.4.1. Pharmaceutical & Biotechnology Companies
  • 9.4.2. CROs
  • 9.4.3. Regulatory Authorities
  • 9.4.4. Academic Research Institutions

Chapter 10. Global Biosimulation Market, Regional Analysis

• 10.1. Biosimulation Market, Regional Market Snapshot
• 10.2. North America Biosimulation Market
  • 10.2.1. U.S. Biosimulation Market
    • 10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
    • 10.2.1.2. Application breakdown estimates & forecasts, 2018-2028
    • 10.2.1.3. Delivery model breakdown estimates & forecasts, 2018-2028
    • 10.2.1.4. End-Use breakdown estimates & forecasts, 2018-2028
  • 10.2.2. Canada Biosimulation Market
• 10.3. Europe Biosimulation Market Snapshot
  • 10.3.1. U.K. Biosimulation Market
  • 10.3.2. Germany Biosimulation Market
  • 10.3.3. France Biosimulation Market
  • 10.3.4. Spain Biosimulation Market
  • 10.3.5. Italy Biosimulation Market
  • 10.3.6. Rest of Europe Biosimulation Market
• 10.4. Asia-Pacific Biosimulation Market Snapshot
  • 10.4.1. China Biosimulation Market
  • 10.4.2. India Biosimulation Market
  • 10.4.3. Japan Biosimulation Market
  • 10.4.4. Australia Biosimulation Market
  • 10.4.5. South Korea Biosimulation Market
  • 10.4.6. Rest of Asia Pacific Biosimulation Market
• 10.5. Latin America Biosimulation Market Snapshot
  • 10.5.1. Brazil Biosimulation Market
  • 10.5.2. Mexico Biosimulation Market
• 10.6. Rest of The World Biosimulation Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Company Profiles
  • 11.2.1. Certara, USA
    • 11.2.1.1. Key Information
    • 11.2.1.2. Overview
    • 11.2.1.3. Financial (Subject to Data Availability)
    • 11.2.1.4. Product Summary
    • 11.2.1.5. Recent Developments
  • 11.2.2. Simulations Plus
  • 11.2.3. Dassault Systemes
  • 11.2.4. Schrodinger, Inc.
  • 11.2.5. Advanced Chemistry Development
  • 11.2.6. Chemical Computing Group ULC
  • 11.2.7. Physiomics Plc
  • 11.2.8. Rosa & Co. LLC
  • 11.2.9. Biosimulation Consulting Inc.
  • 11.2.10. Genedata AG

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Biosimulation Market, report scope
• TABLE 2. Global Biosimulation Market estimates & forecasts by Region 2018-2028 (USD Billion)
• TABLE 3. Global Biosimulation Market estimates & forecasts by Product 2018-2028 (USD Billion)
• TABLE 4. Global Biosimulation Market estimates & forecasts by Application 2018-2028 (USD Billion)
• TABLE 5. Global Biosimulation Market estimates & forecasts by Delivery Model 2018-2028 (USD Billion)
• TABLE 6. Global Biosimulation Market estimates & forecasts by End-Use 2018-2028 (USD Billion)
• TABLE 7. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 8. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 9. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 10. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 11. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 12. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 13. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 14. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 15. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 16. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 17. U.S. Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 18. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 19. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 20. Canada Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 21. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 22. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 23. UK Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 24. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 25. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 26. Germany Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 27. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 28. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 29. RoE Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 30. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 31. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 32. China Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 33. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 34. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 35. India Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 36. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 37. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 38. Japan Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 39. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 40. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 41. RoAPAC Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 42. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 43. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 44. Brazil Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 45. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 46. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 47. Mexico Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 48. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 49. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 50. RoLA Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 51. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 52. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 53. Row Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 54. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 55. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 56. List of secondary sources, used in the study of global Biosimulation Market
• TABLE 57. List of primary sources, used in the study of global Biosimulation Market
• TABLE 58. Years considered for the study
• TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Biosimulation Market, research methodology
• FIG 2. Global Biosimulation Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Biosimulation Market, key trends 2021
• FIG 5. Global Biosimulation Market, growth prospects 2022-2028
• FIG 6. Global Biosimulation Market, porters 5 force model
• FIG 7. Global Biosimulation Market, pest analysis
• FIG 8. Global Biosimulation Market, value chain analysis
• FIG 9. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 10. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 11. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 12. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 13. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 14. Global Biosimulation Market, regional snapshot 2018 & 2028
• FIG 15. North America Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 16. Europe Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 17. Asia Pacific Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 18. Latin America Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 19. Global Biosimulation Market, company Market share analysis (2021)